Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula M Jacobs

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Radiology|September 21, 2021
Deep Disparities Persist in Lung Cancer Screening EligibilityPaula M Jacobs, Sanya A Springfield
American Journal of Nephrology|August 10, 2005
Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patientsRobert Landry, Paula M Jacobs, Robert Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2018
How Advances in Imaging Will Affect Precision Radiation OncologyDavid A Jaffray, Shiva Das, Paula M Jacobs, et al.
AJNR. American Journal of Neuroradiology|October 13, 2005
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesionsSándor P Manninger, Leslie L Muldoon, Gary Nesbit, et al.
Investigative Radiology|February 17, 2006
Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agentPhilippe Bourrinet, Howard H Bengele, Bruno Bonnemain, et al.
Kidney International|September 17, 2005
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patientsBruce S Spinowitz, Michael H Schwenk, Paula M Jacobs, et al.
Journal of Translational Medicine|December 28, 2019
A spontaneously metastatic model of bladder cancer: imaging characterizationJames L Tatum, Joseph D Kalen, Paula M Jacobs, et al.
Kidney International|October 10, 2008
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?Edward A Neuwelt, Bronwyn E Hamilton, Csanad G Varallyay, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2011) e-Century Publishing CorporationBelinda Seto, Paula M Jacobs, Robert H Mach, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 13, 2012
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing CorporationBelinda Seto, Paula M Jacobs, Robert H Mach, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Radiology|September 21, 2021
Deep Disparities Persist in Lung Cancer Screening EligibilityPaula M Jacobs, Sanya A Springfield
American Journal of Nephrology|August 10, 2005
Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patientsRobert Landry, Paula M Jacobs, Robert Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2018
How Advances in Imaging Will Affect Precision Radiation OncologyDavid A Jaffray, Shiva Das, Paula M Jacobs, et al.
AJNR. American Journal of Neuroradiology|October 13, 2005
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesionsSándor P Manninger, Leslie L Muldoon, Gary Nesbit, et al.
Investigative Radiology|February 17, 2006
Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agentPhilippe Bourrinet, Howard H Bengele, Bruno Bonnemain, et al.
Kidney International|September 17, 2005
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patientsBruce S Spinowitz, Michael H Schwenk, Paula M Jacobs, et al.
Journal of Translational Medicine|December 28, 2019
A spontaneously metastatic model of bladder cancer: imaging characterizationJames L Tatum, Joseph D Kalen, Paula M Jacobs, et al.
Kidney International|October 10, 2008
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?Edward A Neuwelt, Bronwyn E Hamilton, Csanad G Varallyay, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2011) e-Century Publishing CorporationBelinda Seto, Paula M Jacobs, Robert H Mach, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 13, 2012
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing CorporationBelinda Seto, Paula M Jacobs, Robert H Mach, et al.
Pageof 3